1,990
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Anhydrous reverse micelle nanoparticles: new strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers

, , , , , , , , & show all
Pages 527-538 | Received 26 Oct 2016, Accepted 05 Dec 2016, Published online: 09 Feb 2017

References

  • Affleck R, Haynes CA, Clark DS. (1992). Solvent dielectric effects on protein dynamics. Proc Natl Acad Sci USA 89:5167–70
  • Antosova Z, Mackova M, Kral V, Macek T. (2009). Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol 27:628–35
  • Bailey MM, Berkland CJ. (2009). Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 29:196–212
  • Bhandari R, Kaur IP. (2013). Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm 441:202–12
  • Buttini F, Miozzi M, Balducci AG, et al. (2014). Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers. Int J Pharm 465:42–51
  • Chen L, Okuda T, Lu XY, Chan HK. (2016). Amorphous powders for inhalation drug delivery. Adv Drug Deliv Rev 100:102–15
  • Chow AHL, Tong HHY, Chattopadhyay P, Shekunov BY. (2007). Particle engineering for pulmonary drug delivery. Pharm Res 24:411–37
  • Creasey RG, Voelcker NH, Schultz CJ. (2012). Investigation of self-assembling proline- and glycine-rich recombinant proteins and peptides inspired by proteins from a symbiotic fungus using atomic force microscopy and circular dichroism spectroscopy. BBA-Proteins Proteom 1824:711–22
  • Cui JX, Li CL, Deng YJ, et al. (2006). Freeze-drying of liposomes using tertiary butyl alcohol/water cosolvent systems. Int J Pharm 312:131–6
  • De Waard H, Hinrichs WLJ, Frijlink HW. (2008). A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J Control Rel 128:179–83
  • Dellamary LA, Tarara TE, Smith DJ, et al. (2000). Hollow porous particles in metered dose inhalers. Pharm Res 17:168–74
  • Doub WH, Shah V, Limb S, et al. (2014). Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers. J Pharm Sci 103:3648–56
  • Fort AG, Duffy HS, Delmar M, Spray DC. (2002). Circular dichroism (cd) studies of peptides corresponding to cytoplasmic domains of gap junction proteins. Biophys J 82:632a–3a
  • Greenfield NJ. (2006). Analysis of the kinetics of folding of proteins and peptides using circular dichroism. Nat Protoc 1:2891–9
  • Haughney J, Price D, Barnes NC, et al. (2010). Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs. Resp Med 104:1237–45
  • Hollosi M, Vass E, Szilvagyi G, et al. (2012). Structure analysis of proteins, peptides and metal complexes by vibrational circular dichroism. Arkivoc Arch Organic Chem 5:291–300
  • Huang CLH, Sun L, Moonga BS, Zaidi M. (2006). Molecular physiology and pharmacology of calcitonin. Cell Mol Biol (Noisy-le-grand) 52:33–43
  • Ibrahim M, Garcia-Contreras L. (2013). Mechanisms of absorption and elimination of drugs administered by inhalation. Ther Deliv 4:1027–45
  • Ivey JW, Vehring R, Finlay WH. (2015). Understanding pressurized metered dose inhaler performance. Expert Opin Drug Deliv 12:901–16
  • Kasra Kasraian PPD. (1995). Thermal analysis of the tertiary butyl alcohol–water system and its implications on freeze-drying. Pharm Res 12:484–90
  • Kasraian K, Deluca PP. (1995). The effect of tertiary butyl alcohol on the resistance of the dry product layer during primary drying. Pharm Res 12:491–5
  • Kaur R, Garg T, Malik B, et al. (2016). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv 23:882–7
  • Kirby CJ. (2000). Oil-based formulations for oral delivery of therapeutic peptides. J Liposome Res 10:391–407
  • Lee TH, Cheng WT, Lin SY. (2010). Thermal stability and conformational structure of salmon calcitonin in the solid and liquid states. Biopolymers 93:200–7
  • Lee TH, Lin SY. (2011). Pluronic F68 enhanced the conformational stability of salmon calcitonin in both aqueous solution and lyophilized solid form. Biopolymers 95:785–91
  • Leeb E, Gotz A, Letzel T, et al. (2015). Influence of denaturation and aggregation of beta-lactoglobulin on its tryptic hydrolysis and the release of functional peptides. Food Chem 187:545–54
  • Li YZ, Sun X, Gong T, et al. (2010). Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm Res 27:1977–86
  • Lombry C, Bosquillon C, Preat V, Vanbever R. (2002). Confocal imaging of rat lungs following intratracheal delivery of dry powders or solutions of fluorescent probes. J Control Rel 83:331–41
  • Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC. (2003). Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech 4:425–33
  • Momoh MA, Kenechukwu FC, Attama AA. (2013). Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Deliv 20:102–11
  • Nyambura BK, Kellaway IW, Taylor KMG. (2009). The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants. Int J Pharm 372:140–6
  • Selvam P, Bharatwaj B, Porcar L, Da Rocha SRP. (2012). Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics. Int J Pharm 422:428–35
  • Shan Z, Tan Y, Qin L, et al. (2014). Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants. Int J Pharm 466:390–9
  • Sharma K, Somavarapu S, Colombani A, et al. (2012). Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers. Eur J Pharm Biopharm 81:74–81
  • Shoyele SA, Slowey A. (2006). Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery. Int J Pharm 314:1–8
  • Souillac PO, Middaugh CR, Rytting JH. (2002). Investigation of protein/carbohydrate interactions in the dried state. 2. Diffuse reflectance FTIR studies. Int J Pharm 235:207–18
  • Stone KC, Mercer RR, Gehr P, et al. (1992). Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 6:235–43
  • Tan Y, Yang Z, Pan X, et al. (2012). Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process. Int J Pharm 427:385–92
  • Tan Y, Yang Z, Peng X, et al. (2011). A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants. Int J Pharm 413:167–73
  • Touitou E, Illum L. (2013). Nasal drug delivery. Drug Deliv Transl Res 3:1–3
  • Weber S, Zimmer A, Pardeike J. (2014). Solid Lipid Nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm 86:7–22
  • Welin-Berger K, Bergenstahl B. (2000). Inhibition of Ostwald ripening in local anesthetic emulsions by using hydrophobic excipients in the disperse phase. Int J Pharm 200:249–60
  • Williams RO, Liu J. (1999). Formulation of a protein with propellant HFA 134a for aerosol delivery. Eur J Pharm Sci 7:137–44
  • Zhang J, Wu LB, Chan HK, Watanabe W. (2011). Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev 63:441–55